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Abstract
Background: Ten-Eleven Translocation (TETs)proteins mediate the oxidation of 5-methylcytosine (5mC) to 5-
hydroxymethylcytosine (5hmC). Tet1 is expressed at high levels in mouse embryonic stem cells (ESCs), where it
mediates the induction of 5hmC decoration on gene-regulatory elements. While the function of Tet1 is known, the
mechanisms of its specificity remain unclear.
Results: We perform a genome-wide comparative analysis of 5hmC in pluripotent ESCs, as well as in differentiated
embryonic and adult cells. We find that 5hmC co-localization with Polycomb repressive complex 2 (PRC2) is
specific to ESCs and is absent in differentiated cells. Tet1 in ESCs is distributed on bivalent genes in two
independent pools: one with Sin3a centered at non-hydroxymethylated transcription start sites and another
centered downstream from these sites. This latter pool of Tet1 co-localizes with 5hmC and PRC2. Through co-
immunoprecipitation experiments, we show that Tet1 forms a complex with PRC2 specifically in ESCs. Genome-
wide analysis of 5hmC profiles in ESCs following knockdown of the PRC2 subunit Suz12 shows a reduction of
5hmC within promoter sequences, specifically at H3K27me3-positive regions of bivalent promoters.
Conclusions: In ESCs, PRC2 recruits Tet1 to chromatin at H3K27me3 positive regions of the genome, with 5hmC
enriched in a broad peak centered 455 bp after the transcription start site and dependent on the PRC2
component Suz12. These results suggest that PRC2-dependent recruitment of Tet1 contributes to epigenetic
plasticity throughout cell differentiation.
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Background
In eukaryotic cells, 5-methylcytosine (5mC) occurs
almost exclusively within a CpG context, and is catalyzed
by the family of DNA methyltransferase (DNMT)
enzymes [1-3]. More recently, a number of studies have
identified a mechanism of DNA demethylation involving
the oxidation of 5mC to 5-hydroxymethylcytosine
(5hmC), which can function as a new epigenetic marker
or as an intermediate toward further oxidative states by
Ten-eleven translocation (TET) proteins [4-11]. In
embryonic stem cells (ESCs) and in embryonic and adult
tissues, 5hmC modification occurs at high levels, whereas
it is significantly reduced in cancer[12-17]. In ESCs,
5hmC is principally catalyzed by Tet1, which has high
expression in these cells. Genome-wide studies in ESCs
have shown 5hmC enrichment on regulatory elements,
such as promoters, enhancers, and gene bodies [18-27].
Tet1 depletion in ESCs leads to both transcriptional
activation, in accordance with its role in oxidation of
5mC, and transcriptional repression [6,20,25,28-32].
Genome-wide analysis have shown that Tet1 binding cor-
relates with the transcriptional repressor Sin3a, which
forms a nuclear complex with Tet1 and also with the
Polycomb repressive complex 2 (PRC2) [19,23,25,32].
PRC2 is the enzymatic complex that mediates the tri-
methylation of lysine 27 of histone H3 (H3K27me3) on
developmental genes that determine whether the chromatin
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remains either open or fully inaccessible. It is formed by
a core complex that includes Enhancer of Zeste 1 or 2
homolog (Ezh1 or Ezh2), Suppressor of Zeste 12 homolog
(Suz12), Embryonic ectoderm development (Eed), and
other accessory subunits, many of which are specific to
ESCs [33-41]. PRC2 is involved in a number of different
biological processes, and its dysregulation is associated with
carcinogenesis [33,42].
Using genome-wide analysis of 5hmC distribution in
ESCs with respect to embryonic and adult tissues, we
found that the overlap between the repressive modification
H3K27me3 and 5hmC is ESC-specific, and we studied the
molecular mechanism of the interplay between Tet1 and
PRC2 in ESC.
Results
Genome-wide distribution of 5hmC in ESCs and
differentiated cells
We mapped the genome-wide distribution of 5hmC
using the glucosylation, periodate oxidation, biotinylation
(GLIB) method followed by sequencing using an Illumina
platform (GLIB-Seq) [18] in ESCs, primary mouse
embryonic fibroblasts (MEFs), and two different tissues
with distinct embryological derivation: brain, which is
known to have high levels of 5hmC, and liver, which is a
homogeneous tissue composed almost exclusively of
hepatocytes.
Heatmaps plotted using the gene expression levels
obtained from RNA sequencing (RNA-Seq) analysis
showed a similar distribution pattern in all samples,
with 5hmC enrichment typically on gene bodies with
respect to the transcription start site (TSS) (Figure 1A).
Classification of the genes by their level of expression
showed an enrichment of 5hmC on upstream promoter
regions and the gene bodies of genes with higher
expression. By contrast, unexpressed genes or genes
expressed at low levels showed an enrichment of 5hmC
at the TSS, which was more evident in undifferentiated
ESCs (Figure 1B). To further investigate the relationship
between hydroxymethylation and tissue specificity, we
analyzed the distribution of 5hmC for genes expressed
in the liver by separating them in two groups: liver-specific
genes and housekeeping genes. Notably, liver-specific
genes showed 5hmC enrichment only on the upstream
region and along the genes in the liver itself, whereas they
showed increased 5hmC at the TSSs in ESCs, MEFs, and
brain tissue (Figure 1C, left panels). Conversely, the house-
keeping genes in all cell types had 5hmC distributed at
upstream promoter regions and in the gene bodies but not
at the TSS (Figure 1C, right panels).
For each cell type, we then plotted the expression level
(reads per kb of exon per million mapped reads (RPKM)
log10) and the 5hmC intensity normalized for the gene
length for each gene to further clarify the role of 5hmC
in gene expression (see Additional file 1 Figure S1). This
analysis identified 5hmC enrichment at genes with medium
expression levels, with a peak around RPKM log10 value = 1
(Figure 1C), whereas genes that were not expressed
(RPKM log10 value <-1) or expressed at very high levels
(RPKM log10 value ≥3) showed little or no 5hmC.
The examples (see Additional file 1: Figure S1) show
the 5hmC distribution and transcript levels of the
Pou5f1 and Albumin genes, which are highly expressed
in ESCs and liver, respectively, and Eef1a1, which is
highly expressed in all four cell types. Taken together,
these results show that 5hmC is enriched on the TSSs
of genes that are not expressed or are expressed at low
levels, whereas genes that are more highly expressed
show an enrichment of 5hmC along the gene but not at
TSSs, independent of the cell type.
5hmC correlates with PRC2 and H3K27me3 in ESCs, but
not in differentiated cells
Recent studies in ESCs have highlighted 5hmC enrich-
ment on specific genomic elements and in association
with some histone modifications [18-20,24-26,29,32]. We
extended this analysis by comparing ESCs with differen-
tiated MEFs, and brain and liver tissues. Analysis of 5hmC
density on promoters and gene bodies normalized accor-
ding to base pair length showed that 5hmC was signi-
ficantly enriched on promoters in ESCs but not in
differentiated cells,(Figure 2A).
As previously observed, the exons in ESCs showed
higher levels of DNA hydroxymethylation than did the
introns, and this difference was confirmed in the other cell
types we analyzed (Figure 2B). By contrast, the DNA of
active enhancers was enriched by hydroxymethylation in
ESCs, whereas this correlation was inverted in differen-
tiated cells (Figure 2C). We also found significant 5hmC
enrichment in promoters with low or intermediate CpG
content (LCP and ICP, respectively) compared with high
CpG (HCP) content in all cell types analyzed (Figure 2D).
Importantly, we found strong enrichment of 5hmC on
H3K4me3K27me3 double-positive and H3K27me3-
positive promoters compared with H3K4me3-positive
promoters in ESCs but not in the other cell types (Figure
2E). Further comparison of our data with published histone
modifications and transcription factor occupancy confirmed
that, in ESCs, 5hmC co-localizes with H3K27me3, as well
as with Ezh2 and Suz12 binding (Figure 2F; see Additional
file 1: Figure S2)
Analysis of the genome-wide distribution of 5hmC
and H3K27me3 at promoters (± 5 kb) of all genes,
ordered by expression level, showed that H3K27me3 is
more abundant on promoters of genes with low expres-
sion in all cell types. However, in ESCs only, H3K27me3
promoters showed a significant enrichment of 5hmC
(Figure 3A,B).
Neri et al. Genome Biology 2013, 14:R91
http://genomebiology.com/content/14/8/R91
Page 2 of 13
Figure 1 5hmC distribution in pluripotent and differentiated cells. (A) Heatmaps of 5hmC occupancy on promoters and gene bodies in
embryonic stem cells (ESCs), mouse embryonic fibroblasts (MEFs), and brain and liver tissue. Genes are ordered by the mRNA levels of each cell
type obtained by RNA sequencing (RNA-Seq) analysis. (B) The 5hmC distribution profile in promoter regions and gene bodies of genes grouped
into three equal sets by their mRNA expression level. (C) Heatmaps and distribution profiles of 5hmC in promoters and gene bodies of genes
separated into two groups according to their expression level, as expressed only in liver (liver-specific) or expressed in in ESCs, MEFs, brain, and
liver (housekeeping genes). (D) Scatter plot of 5hmC gene body density and expression level for each gene in ESCs, MEFs, brain, and liver.
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Tet1 bimodal binding profile in H3K27me3 positive
promoters
The above data show a correlation between 5hmC and
H3K27me3 distribution on ESC promoters. Further ana-
lysis of Tet1 distribution, using published chromatin
immunoprecipitation sequencing (ChIP-Seq) datasets
[25][32], on genes ordered by level of H3K27me3,
showed that Tet1 binding correlates with Ezh2 and
Suz12, as well as with Sin3a, a protein recently discovered
in complex with Tet1 [25] (Figure 4A). Approximately
84% of Suz12 and 47% of Sin3a binding sites were also
bound by Tet1, whereas the overlap between Sin3a and
Suz12 was low (see Additional file 1, Figure S3).
Moreover, Tet1-Sin3a co-bound peaks showed high
CpG island content, whereas the number of CpG islands
was significantly decreased in Tet1-H3K27me3 co-bound
regions (see Additional file 1, Figure S3).
Using unsupervised analysis of Tet1 binding, with a
k-means clustering algorithm based on the Pearson cor-
relation coefficient across profiles, we generated binding
profile curves across each promoter (± 5 kb). After
separating the results into two clusters (k = 2), we
obtained two different Tet1 binding profiles: cluster 1,
with a profile centered on the TSS and enriched at K4-
only genes; and cluster 2, with a larger profile centered
downstream from the TSS enriched on bivalent promoters
(Figure 4B). Next, we plotted the Tet1 peaks around the
TSS. On H3K27me3-negative genes, the Tet1 binding
overlapped with Sin3a (Figure 4C, upper panel). Interest-
ingly, on H3K27me3-positive genes, Tet1 displayed a
bimodal profile that correlated with Sin3a on the TSS and
with Suz12 downstream of the TSS (Figure 4C, lower
panel). Fitting the Tet1 binding curve on the TSS (± 5 kb)
using a superposition of two Gaussian distributions
(six parameters fit, see Methods) showed that the first
Gaussian curve was narrower and centered 39 bp
upstream of the TSS, whereas the second was broader and
centered 455 bp downstream of the TSS (Figure 4D).
Taken together, these data suggest that Tet1 is present on
bivalent genes in two distinct pools, one overlapping with
Sin3a and the other with Suz12.
PRC2 interacts with Tet1 in ESC, and its binding is
required for DNA hydroxymethylation at bivalent genes
The data above suggest interplay between Tet1 and
PRC2 in ESCs. Next, we examined whether Tet1 could
Figure 2 5hmC distribution on genomic elements and histone modifications. The percentage of 5hmC was normalized to the length (bp)
of each genomic segment considered. (A) 5hmC was enriched on promoters (± 1 kb) in embryonic stem cells (ESCs) (*P < 0.01).(B) 5hmC was
enriched on exons with respect to introns (*P < 0.01).(C) 5hmC was significantly enriched in active enhancers in ESCs and in poised enhancers
in differentiated tissues (*P < 0.01; **P < 0.05).(D) Promoters with low and intermediate presence of CpG islands (LCP and ICP, respectively) were
preferentially marked by DNA hydroxymethylation with respect to promoters with high CpG (HCP) (*P < 0.01). (E) In ESCs, promoters with both
H3K4me3 and H3K27me3 (K4/K27) and promoters with H3K27me3 but not H3K4me3 (K27) were significantly enriched in DNA
hydroxymethylation compared with promoters with H3K4me3 but not H3K27me3 (K4) (*P < 0.01). (F) Analysis of correlations between 5hmC
and histone modifications in all four cell types (*P < 0.01).
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form a complex with PRC2 by co-immunoprecipitation
of the endogenous proteins from ESCs and MEFs. Tet1
was co-immunoprecipitated with the PRC2 subunits
Suz12 and Ezh2 in ESCs (Figure 5A). The reciprocal
immunoprecipitation experiment with a Suz12 antibody
showed association of PRC2 with Tet1 (Figure 5B).
Notably, we did not observe PRC2 co-immunoprecipitation
with Tet1 in MEFs (Figure 5A,B), whereas Sin3a was
co-immunoprecipitated with Tet1 in both cell lines,
thus confirming that the physical connection between
Tet1 and PRC2 complex is limited to ESCs. To test
whether the Tet1/PRC2 interaction is necessary for DNA
hydroxymethylation at H3K27me3 regions, we silenced
Suz12 in ESCs using two different small hairpin (sh)RNAs.
Both constructs decreased Suz12 protein and H3K27me3
levels without affecting the levels of Tet1 or Sin3a (Figure
5C; see Additional file 1: Figure S3). Suz12 silencing
resulted in a significant reduction of global DNA hydroxy-
methylation (Figure 5D; see Additional file 1: Figure S3).
Genome-wide analysis of 5hmC profiles in control and
Suz12 knockdown ESCs showed a reduction of 5hmC at
the promoter regions of H3K27me3-positive genes within
the Tet1 co-bound regions but not at H3K27me3-negative
regions (Figure 6A,B; see Additional file 1, Figure S4).
Figure 3 5hmC was enriched at H3K27me3 loci in embryonic stem cells (ESCs) but not in differentiated cells. (A) Heatmaps of 5hmC
and H3K27me3 of genomic regions around the TSS (± 5 kb) in ESCs, mouse embryonic fibroblasts (MEFs), brain, and liver, rank-ordered by
mRNA expression level of each cell type. (B) Profile distribution of 5hmC and H3K27me3 at the TSS (± 5kb) in H3K27me3-positive genes.
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Figure 4 Bimodal distribution of Tet1 on bivalent genes. (A) Heatmaps of H3K4me3, H3K27me3, 5hmC, Ezh2, Suz12, Tet1-C [25], Tet1-N [25],
Tet1-Wu [32], Sin3a #1 (Abcam), and Sin3a #2 (Santa Cruz Biotechnology) on the transcription start site (TSS) of genes rank-ordered by their
H3K27me3 level. (B) Distribution frequency of Tet1 binding obtained by clustering of Tet1 binding data by k-means algorithm revealed two
different Tet1 occupancy profiles on gene promoters.(C) Tet1, Sin3a and Suz12 occupancy around the TSS (± 2 kb) of H3K27me3-negative
(upper panel) or H3K27me3-positive (lower panel) genes. (D) Fitting of the Tet1 binding in H3K27me3-positive genes revealed two Gaussian
profiles, one centered -39 bp upstream from the TSS, and the other centered +455 bp downstream from the TSS.
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Figure 5 PRC2 interacts with Tet1 and is required for correct DNA hydroxymethylation. (A) Nuclear extracts of embryonic stem cells
(ESCs) or mouse embryonic fibroblasts (MEFs) were immunoprecipitated with anti-IgG or anti-Tet1 antibodies. Western blotting analysis was
performed using the antibodies indicated. For each input, 1% of nuclear extract was loaded. (B) Nuclear extracts of ESCs or MEFs were
immunoprecipitated with anti-IgG or anti-Suz12 antibodies. Western blotting analysis was performed using the antibodies indicated. For each
input, 2% of nuclear extract was loaded. (C) Western blotting analysis of extracts from the control (small hairpin green fluorescent protein;
shGFP) or Suz12 knockdown (shSuz12) ESCs was performed using the antibodies indicated. (D) Dot-blot analysis and signal quantification of
5hmC and 5mC in DNA extracted from control or Suz12 knockdown ESCs. Single-stranded (ss)DNA was used as a loading control. The
experiments were performed in triplicate.
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ChIP analysis of Tet1 binding to the bivalent genes
Kdr and Hoxa1 and the non-bivalent genes Cdc25a and
Pou5f1 in wild-type and Suz12-silenced cells showed a
reduction of Tet1 binding only at Tet1-PRC2 co-bound
regions (Figure 6C; see Additional file 1: Figure S4).
Taken together, these results indicate that PRC2 is
required for recruitment of Tet1 and DNA hydroxy-
methylation on bivalent promoters.
Discussion
We compared the genome-wide distribution of 5hmC in
ESCs, MEF, and terminally differentiated brain and liver
tissues by GLIB-Seq analysis, which identified a similar
enrichment of 5hmC on promoters, enhancers, and
gene bodies, with a preference for exons in all cell types.
A major difference between ESCs and other cell types is
the correlation between 5hmC and H3K27me3, which is
unique to ESCs, whereas this correlation is not present in
differentiated fibroblasts or in adult tissues. We found
that this difference is due to an ESC-specific functional
interplay between Tet1 and the PRC2 complex.
We found that in ESCs, but not in differentiated cells,
PRC2 recruits Tet1 to the chromatin of bivalent genes
to maintain their hypomethylated state. First, through
in-depth analysis of previous ChIP-Seq data in ESCs, we
found that Tet1 binds to chromatin with two different
binding profiles: one, which is characterized by narrow
peaks, is centered on the TSS of almost all genes and over-
laps with Sin3a, while the other, which is characterized by
broader peaks, is centered downstream of the promoters
of bivalent genes and overlaps with PRC2. Second, co-im-
munoprecipitation showed that Tet1 interacts with PRC2
in ESCs but not in fibroblasts. Third, in ESCs, Suz12
silencing affected Tet1 binding and 5hmC modification
at bivalent promoters specifically at PRC2-positive
regions but not at other regions.
Thus, our results show that Tet1, besides binding at
the TSS together with Sin3a, is recruited by PRC2
downstream from the TSS at bivalent genes. The differ-
ence in the peak shape of the two binding profiles is com-
patible with the different recruitment mechanisms. In one
case, Tet1 binds directly to the DNA on the TSS via its
CXXC domain, which has high affinity for clustered
unmethylated CpG dinucleotides [11], whereas in the
other case, Tet1 is recruited by PRC2 to the chromatin. In
this latter case, the binding of Tet1 and the distribution of
5hmC occupy larger regions, owing to the typical spread
of PRC2 binding on bivalent promoters. Interestingly,
Tet1, together with Sin3a, localizes to unmethylated TSSs,
suggesting that, at these regions, this complex binds to
unmethylated CpG or catalyzes the oxidation of 5mC to
completion. Conversely, Tet1 binding with PRC2 overlaps
with 5hmC on bivalent genes. Thus, our results are com-
patible with a model by which Tet1-dependent oxidation
of 5mC is finely regulated to either eliminate DNA methy-
lation or generate 5hmC epigenetic marks in different
regions. Previous findings that MeCP2, Np95, and Mbd3
recognize 5hmC [10,43-45] imply that this DNA modifi-
cation can be a specific epigenetic signal.
We found that PRC2 depletion from ESCs reduced Tet1
binding on bivalent promoters. This result differs from
previous studies reporting that Ezh2 knockdown did not
affect Tet1 binding [32]. This discrepancy could be
because depletion of Ezh2 does not impair PRC2 binding
to the chromatin or its methylation activity, because in
ESCs, Ezh1 can complement Ezh2 function [39]. By con-
trast, knockdown of Suz12 destabilizes the complex [37].
We found that Tet1/PRC2 co-immunoprecipitation is
ESC-specific, as we could not co-immunoprecipitate Tet1
with PRC2 in fibroblasts, and previous experiments failed
to detect PRC2 proteins interacting with Tet1 in HEK293
cells [25]. These results suggest that the functional interac-
tion between Tet1 and PRC2 in ESCs is either indirect,
possibly mediated by one of the ESC-specific cofactors, or
is dependent on post-translation modifications.
We also found that the distribution of 5hmC on gene
bodies is not tissue-specific, but increases with the level
of gene expression in all cell types analyzed, suggesting
that 5hmC acts as a positive activator by reducing the
5mC level. This regulation is confirmed by the recent
finding that 5hmC was increased in gene bodies that
were transcriptionally upregulated in a model of neuro-
nal differentiation [46]. However, we found that genes
expressed at very high levels showed little or no 5hmC,
suggesting that DNA hydroxymethylation is not neutral
but is mildly inhibitory on the transcription process.
These results agree with in vitro experiments showing
that 5hmC modifications are mildly repressive when
present in the gene body [47].
We reported that PRC2 depletion reduced Tet1 bind-
ing and the presence of 5hmC at promoters of bivalent
genes in ESCs. A previous report showed that Tet1
depletion results in the increased methylation and
minor binding of PRC2 [32], most likely because Tet1-
dependent demethylation facilitates PRC2 recruitment
to the DNA, as methyl CpG counteracts the binding of
PRC2. In fact, genome-wide analysis reported mutual
exclusiveness of H3K27me3 with DNA methylation in
CpG islands [48-51], and DNA methylation inhibits the
binding of PRC2 in vitro [50]. Taken together, these
results suggest a positive feedback loop between Tet1-
dependent DNA demethylation and PRC2-dependent
repression through H3K27me3 in ESCs in order to
maintain developmental genes in the poised status.
Thus, the presence of these two contrasting epigenetic
markers on the same chromatin region is required to
allow activation or repression of bivalent genes following
action of developmental stimuli.
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Figure 6 Polycomb repressive complex 2 (PRC2) is required for 5hmC deposition and Tet1 binding in Tet1-PRC2 co-bound regions. (A)
Heatmaps and distribution profiles of 5hmC around the transcription start site (TSS) of genes rank-ordered by H3K27me3 levels in control or
Suz12 knockdown embryonic stem cells (ESCs) See also Figure S3(C-E). (B) Sin3a, Tet1, H3K27me3, Suz12 occupancy and 5hmC occupancy in
control and Suz12 knockdown cells on representative examples of bivalent (Kdr and Hoxa1) and K4-only (Cdc25a and Pou5f1) genes. Chromatin
immunoprecipitation (ChIP) analysis of Tet1 binding of genomic regions (a to n) as indicated in panel (A), in control or Suz12 knockdown ESCs
(*P < 0.01).
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Conclusions
Using genome-wide analysis, Suz12 silencing, and
immunoprecipitation experiments we found that in
ESCs, but not in other cell types, PRC2 recruits Tet1 to
H3K27me3 regions. Our results identify a novel way by
which Tet1 is recruited onto the chromatin, indepen-
dent of its ability to bind directly to CpG or to be
recruited by Sin3a, and clarify the mechanism that links
H3K27me3 modifications on the nucleosome and 5hmC
on the DNA in ESCs. These findings highlight the
mechanistic link between PRC2 and Tet1 and contribute
to our understanding of how these two epigenetic modi-
fiers regulate the chromatin state of bivalent genes to
maintain these bivalent genes in a poised state, ensuring
their dynamic regulation during differentiation.
Materials and methods
Cell culture
E14 mouse ES cells were cultured in high-glucose
DMEM (Invitrogen Corp., Carlsbad, CA, USA) supple-
mented with 15% FBS (Millipore Corp., Billerica, MA,
USA), 0.1 mmol/l nonessential amino acids (Invitrogen),
1 mmol/l sodium pyruvate (Invitrogen), 0.1 mmol/l 2-
mercaptoethanol, 1500 U/ml Leukemia Inhibitory Factor
(LIF; Millipore), 25 U/ml penicillin, and 25 µg/ml strep-
tomycin. MEFs were derived from 13.5 day pregnant
female mice and cultured in high-glucose DMEM sup-
plemented with 10% FCS. Mouse tissues were extracted
from 8-week-old mice. For silencing of Suz12, ESCs
were transfected as previously described [52] with the
TRCN0000123889 and TRCN0000123891 vectors (Open
Biosystems/Thermo Scientific Inc., Ptitsburgh PA, USA)
and then maintained for selection for 3 days with 1 µg/ml
puromycin.
DNA extraction and GLIB-Seq
Genomic DNA was extracted using a DNeasy Blood and
Tissue kit (Qiagen Inc., Valencia, CA, USA).
GLIB was precipitated using a Hydroxymethyl Collector
(Active Motif, Carlsbad, CA, USA). Libraries were gener-
ated with a ChIP-Seq Sample Prep Kit (Illumina Inc.,
San Diego, CA, USA) and sequenced on an HiScanSQ
Platform (Illumina).
Bioinformatic analysis
Sequencing data were mapped to the mouse genome
(mm9 assembly) using Bowtie (version 0.12.7), reporting
only unique hits with up to two mismatches. Redundan-
cies were collapsed, and peak calling was performed
using MACS (version 1.4.1). For comparative analysis,
we downloaded GEO Datasets data for the ESC histone
modifications GSE12241 [53,54] and GSE11172 [55],
and the transcription factors GSE11431 [56], GSE24843
[25], and GSE26833 [19,32]. For histone modifications
and mRNA expression, ChIP-Seq and RNA-Seq data on
ESCs, MEFs, and brain or liver tissues were downloaded
from the ENCODE project database [57], corresponding
to the following GEO Datasets: GSE36025, GSE36026,
and GSE31039. Datasets for ChIP-Seq of H3K27me3 on
MEFs was downloaded from GSE12241.
LCP-ICP-HCP promoters were defined as described by
Weber et al. [58], H3K4me3-only and bivalent promoters
were defined as described by Ku et al. [59], and active or
poised enhancers were defined as previously described
[60,61]. To obtain three groups of equal size, genes with
RPKM less than 0.1, 0.1 to 5, and less 5 were categorized
as having no, low, and medium/high expression, respec-
tively. Liver-specific genes were defined as having RPKM
less than 10 in liver and less than 1 in other cells. House-
keeping genes were defined as RPKM greater than 10 in
all cell types.
Data mapped on the mouse mm8 assembly was trans-
posed to the mm9 assembly using the liftOver tool.
Heatmaps and comparative analyses were performed
using custom Perl scripts. Clustering of Tet1 binding
profiles was performed using the MATLAB implementa-
tion of the k-means algorithm using the Pearson correla-
tion coefficient as the ‘distance’ between profiles. Using
100 realizations of the clustering (using different random
seeds), we foudn that the composition of clusters was
remarkably stable. The fitting procedure of the average
Tet1 binding profile was performed using the gnuplot
least squares fitting algorithm. The test function was a
superposition of two (non-normalized) Gaussian distribu-
tions (six parameters fit: two means, two variances, one
relative weight, one overall amplitude factor).
Nuclear protein extractions
Cells were harvested in 1× PBS and resuspended in iso-
tonic buffer (20 mmol/l HEPES pH 7.5, 100 mmol/l
NaCl, 250 mmol/l sucrose, 5 mmol/l MgCl2, 5 µmol/l
ZnCl2), then cells were resuspended in isotonic buffer
supplemented with 1% NP-40 to isolate nuclei. The
isolated nuclei were resuspended in digestion buffer
(50 mmol/l Tris-HCl pH 8.0, 100 mmol/l NaCl, 250
mmol/l Sucrose, 0.5 mmol/l MgCl2, 5 mmol/l CaCl2,
5 µmol/l ZnCl2), and treated with microccocal nuclease
at 30°C for 10 min.
Immunoprecipitations
Nuclear proteins were incubated with 3 µg of specific
antibody overnight at 4°C. Immunocomplexes were
incubated with Protein G-conjugated magnetic beads
(Dynal; Invitrogen) for 2 h at 4°C. Samples were washed
four times with digestion buffer supplemented with 0.1%
NP-40 at room temperature. Proteins were eluted by
incubating with 0.4 M NaCl TE buffer for 30 min, and
analyzed by western blotting as previously described [62].
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Chromatin immunoprecipitation and dot-blot analysis
Each ChIP experiment was performed at least three inde-
pendent times, as previously described [52]. Oligonucleo-
tide sequences are shown in the supplementary data. See
Additional file 1. Genomic DNA for the dot-blot analysis
was sonicated for 15 cycles and denatured with 0.4 M
NaOH, then incubated for 10 minutes at 95°C before
being spotted onto Hybond™-N+ membranes (GE Health-
care, Little Chalfont, Buckinghamshire, UK).
Antibodies
The antibodies used were anti-Tet1, anti-H3K27me3,
anti-H3K4me3 (all Millipore), anti-ssDNA (Abcam,
Cambridge, MA, USA), anti-Suz12and anti-Ezh2 (both-
Cell Signaling Technology, Danvers, MA, USA), anti-
actin (Sigma-Aldrich, St Louis, MO, USA), anti-Sin3a
(SantaCruz Biotechnology Inc., Santa Cruz, CA, USA),
and anti-5mC and anti-5hmC (both Active Motif).
Data access
The Gene Expression Omnibus accession number for
5hmC profiling of ESC, MEF, brain and liver reported in
this paper is GSE44566.
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figures (Figures S1 to S4), and one supplemental table (Table S1).
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